A single and multiple dose trial assessing safety, tolerability, pharmacokinetics and pharmacodynamics of ZP6590

Status

Not yet recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2026-525978-19-00

Enrollment

Registered

2026-06-24

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Weight management

None listed

Sex/Gender

Male

Age

18 Years to 64 Years

None listed

Source: EU CTIS · Data processed: Jun 25, 2026